ID   HROC24 T1 M1
AC   CVCL_1U80
SY   HROC24X
DR   CLS; 300813
DR   Wikidata; Q54895255
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NOD SCID mice.
CC   Doubling time: 20 hours (CLS=300813).
CC   HLA typing: A*02:01,30:02; B*18:01,38:01; C*05:01,12:03; DQB1*02:01,06:01; DRB1*03:01,13:01 (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300813; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 7,8 (Direct_author_submission)
ST   D13S317: 7,13 (CLS=300813)
ST   D16S539: 9,11
ST   D21S11: 27,28
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD57 ! B-LCL-HROC24
OI   CVCL_S853 ! HROC24
OI   CVCL_AN14 ! HROC24 T3 M1 #2
SX   Male
AG   98Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 17
//
RX   PubMed=31601052; DOI=10.3390/cancers11101520; PMCID=PMC6826890;
RA   Mullins C.S., Micheel B., Matschos S., Leuchter M., Burtin F.,
RA   Krohn M., Huhns M., Klar E., Prall F., Linnebacher M.;
RT   "Integrated biobanking and tumor model establishment of human
RT   colorectal carcinoma provides excellent tools for preclinical
RT   research.";
RL   Cancers (Basel) 11:1520.1-1520.18(2019).
//